Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

85.82
Delayed Data
As of 4:02pm ET
 -0.39 / -0.45%
Today’s Change
74.00
Today|||52-Week Range
89.09
+1.61%
Year-to-Date
Oakbrook Investments Llc Buys Apple Inc, Starbucks Corp, Boeing Co, Sells General Ele...
10:38am / GuruFocus News - Paid Partner Content
Dow 30 Stock Roundup: Boeing Q4 Deliveries Up Y/Y, Success for Merck's Keytruda Combo
Jan 12 / Zacks.com - Paid Partner Content
Merck Strong on Confirmatory Phase III Lung Cancer Study
Jan 17 / Zacks.com - Paid Partner Content
Lilly's Elanco/Aratana's Veterinary Medicine Gets EU Nod
Jan 12 / Zacks.com - Paid Partner Content
A Rally in Eli Lilly Could Heal Traders, Investors
Jan 17 / TheStreet.com - Paid Partner Content
Merck's Keytruda on a Roll: Can it Retain the Spark in 2018?
Jan 12 / Zacks.com - Paid Partner Content
Nektar Boasts Strong Pipeline, Competition Remains a Woe
Jan 17 / Zacks.com - Paid Partner Content
Big Pharma CEOs Speak About Impact of Tax Reform on M&A
Jan 11 / Zacks.com - Paid Partner Content
Three Diabetes Clinical Trials to Watch in 2018
Jan 12 / GuruFocus News - Paid Partner Content
FDA Approvals Surge in 2017: Here's a Look at the Numbers
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close86.21
Today’s open86.04
Day’s range85.27 - 86.14
Volume4,445,813
Average volume (3 months)3,244,359
Market cap$94.9B
Data as of 4:02pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)+14.16%
Earnings growth (this year)+19.76%
Earnings growth (next 5 years)+12.35%
Revenue growth (last year)+6.33%
P/E ratio40.9
Price/Sales3.68
Price/Book6.78

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.08+0.14%
NVONovo Nordisk+0.10+0.18%
BMYBristol-Myers Squibb-0.02-0.03%
GSKGlaxoSmithKline+0.02+0.05%
Data as of 4:02pm ET, 01/18/2018

Financials

Next reporting dateJanuary 31, 2018
EPS forecast (this quarter)$1.07
Annual revenue (last year)$21.2B
Annual profit (last year)$2.7B
Net profit margin12.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Chief Financial Officer &
Senior Vice President
Joshua L. Smiley
Corporate headquarters
Indianapolis, Indiana

Forecasts